AUDACIOUS MEDICAL GRANT - ONCOLOGIE (AMG-ONCO) 2026
Fond National de la Recherche Scientifique (F.R.S.-FNRS)
The term “audacious” means that there is a significant risk that the project will produce little or no tangible scientific result because of its novelty or complexity. The AMG-Oncology is not a Télévie related funding instrument but the FNRS uses the expertise of its Scientific Commission to conduct the evaluation of submitted projects. As such, there are no restrictions in terms of application between the AMG-ONCO 2026 call and the Télévie call 2026.
Financement
Voir mini-guide
Pour postuler
Projects must be submitted electronically on the web-based application of the FNRS e-space. Although not a Télévie related instrument, the independent AMG-ONCO form will be accessible via the link “Télévie 2026 call”. The number of applications that can be submitted by a given promoter is limited to one for the 2026 edition.
Requis d'admission
Voir mini-guide
Zones géographiques
Les zones géographiques n'ont pas encore été spécifiées.